600812.SHG North China Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
4.84 CNY
Close of Nov 5, 2026
4.11 6.90
Market cap
CNY 8.30B
P/E
96.8x
P/B
1.45x
ROE
1.6%
Dividend yield
4.97%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600812.SHG undervalued?

Graham number
Price4.84
Graham value1.94
Premium149.9%

600812.SHG trades 149.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

North China Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for North China Pharmaceutical Co Ltd yet.

North China Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About North China Pharmaceutical Co Ltd

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company primarily offers anti-infective, biotechnology, and cardiovascular cerebrovascular drugs; and immunomodulators, vitamins, and health products. It also provides chemical, biological, agricultural, and biopharmaceuticals and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain phar…

Full company profile